Installing implants in the posterior maxilla is made particularly difficult by the ventilation of the maxillary sinus (increasing with age) and the poor quality of bone in this region. Through loss of the teeth of the maxilla and progressive pneumatization of the basal sinus with formation of caudal recesses, bone height in this region may be limited (Plenk & Tschabitscher 1985; Chanavaz 1990; Wehrbein & Diedrich 1992) . The lack of cortical bone and the low density of cancellous bone correlate significantly with reduced implant stability (Misch 1990; Sennerby et al. 1992; Jemt & Lekholm 1993; Spiekermann 1995) .
One method allowing implant insertion in such cases is the sinus floor augmentation procedure described by Boyne & James (1980) and Tatum (1986) . This procedure is intended to increase bone height in the posterior maxilla through formation of new bone in the caudal section of the maxillary sinus. The question as to which material is most appropriate for sinus augmentation is a subject of controversy. There are two basic options for the incorporation of bone substitute materials: osteoconduction and osteoinduction. In osteoconduction, the bone substitute material serves as a conducting structure for the reforming bone. Vascularization and proliferation of osteoprogenitor cells occurs from the local bone transplant site. In contrast, in osteoinduction, the formation of new bone is activated by induction substances, such as BMP (bone morphogenetic protein) and special growth factors which promote differentiation of osteoprogenitor cells in osteoblasts and/or chondroblasts. These osteoinductive properties are ascribed to autogenous bone (Moy et al. 1993) , which is thus regarded as the ''gold'' standard and has the best prognosis as implant site. There are no limitations on autogenous bone material with respect to biocompatibility. The autotransplant, having become necrotic due to insufficient blood supply, is replaced by new, vital bone by ''creeping substitution'' (Burchardt 1987; Schenk 1991) .
Augmentation of the sinus floor using iliac crest bone grafts has resulted in very good clinical success rates (Boyne & James 1980; Kent & Block 1989; Jensen et al. 1990; Rhaghoebar et al. 1993; Keller et al. 1994; Nishibori et al. 1994) . Harvesting autogenous bone requires a second surgical intervention at the iliac crest, increasing the time and cost of treatment and giving rise to considerable morbidity (Gerngroß et al. 1982) . Something approaching 8% of operations for removal of autotransplants result in considerable complications, such as infections, loss of blood as a result of arterial injury, and short-term and long-term pain or functional losses (Younger & Chapman 1989) .
When the autogenous bone is harvested from the maxillofacial region, the success rates for augmentation are also high (Wood & Moore 1988; Hirsch & Ericsson 1991; Jensen & Sindet-Pedersen 1991; Krekeler et al. 1993; Lundgren et al. 1996) . However, the quantity of osseous material which can be harvested from the enoral donor regions, such as the tuber, the retromolar region or the symphysis of the mandible, is frequently insufficient for the surgical procedure which a sinus floor elevation involves.
In clinical application, augmentation using allogenic bone from bone banks shows very divergent results. Besides osteoconductive properties, some publications ascribe osteoinductive properties to 218 allograft due to the presence of bone morphogenetic proteins (Urist 1965; Harakas 1984; Shigeyama et al. 1995; Schwartz et al. 1996; Piatelli et al. 1998) . In contrast, other authors report that in animal experiment and clinical application, demineralized, freeze-dried bone shows no evidence of osteoclastic resorption and no new formation of lamellar bone at its surface (Becker et al. 1994; Becker et al. 1995; Valentini & Abensur 1997) . Allogenic transplants are said to function at best as relatively poor osteoconductors (Jensen et al. 1998) . The additional risk of immune response and the transference of infectious diseases also raise doubts about the use of this material.
Alloplastic materials, such as synthetically manufactured porous hydroxylapatite and tricalcium phosphate, are available in unlimited supply, but have the disadvantage of having only osteoconductive and no osteoinductive properties (Aebi 1991) . The demands made on bone substitute materials in relation to both resorption and pore and particle size have been crucial in the success of these alloplastic substitutes. Some publications provide evidence of good results for the use of alloplastic materials, making it possible to approve their clinical use according to the various fields of indication (Misch 1987; Smiler & Holmes 1987; Jensen et al. 1998) .
Alongside synthetic materials, calcium phosphate materials from natural products are also known: coralline Interpore 200
A (Interpore International, Irvine, California, USA) and bovine BioOss A (Geistlich, Wolhusen, Switzerland), a xenogenic material obtained from calf bones from which all organic components have been removed. Bovine bone substitute material is similar to human cancellous bone both in its crystalline and morphological structure. In addition, the physical properties of Bio-Oss A granulate also approximate to the values for human bone tissue (Table 1) .
In comparison, synthetic hydroxylapatite is stiffer and less flexible, which can result in microfractures and fibrous encapsulation. The large-mesh, interconnecting pore system (75% pores) of xenogenic bone substitute material facilitates angiogenesis and the migration of osteoblasts. Simultaneously, the inner surface becomes greatly enlarged (Bio-Oss A : 100 m 2 /g, HA: 1-10 m 2 /g), which is intended to influence positively the formation and inward growth of new bone, and thus the bonding between transplant material and bone (Peetz 1997) . A study by Cohen et al. (1994) showed that when Bio-Oss A is implanted, the absence of proteins means that no immune response or allergy in vivo is induced. Subsequent to subcutaneous implantation of Bio-Oss A granulate in rats, the authors used 6 monoclonal antibodies to demonstrate the presence of monocytes, macrophages, Ia-antigens, and Tand B-lymphocytes. Apart from an initial macrophage infiltration, lasting 6-8 weeks, it was not possible to demonstrate any local or systemic immune response. This evidence is confirmed by Schlickewei & Paul (1991) using ELISA (enzymelinked immunosorbent assay) with rabbits.
Animal-based experimental studies have repeatedly classified Bio-Oss
A as a suitable bone substitute material (Schlickewei & Paul 1991; Klinge et al. 1992; Wetzel et al. 1995; Berglundh & Lindhe 1997) . This study was therefore directed at the question as to whether the results obtained are correspondingly good when Bio-Oss A is used with humans.
The present investigation should thus provide a histologic and histomorphometric evaluation of the xenogenic bone graft material Bio-Oss A combined with venous blood following sinus floor elevation.
Material and methods
The patient population consisted of 8 women and 3 men (average age 49.6 years, ranging from 39 to 63 years) ( Table 2 ). Preoperative diagnosis, aided by orthopantomographic radiography, showed that for all patients the height of the residual bone in the posterior maxilla was insufficient (on average 1.9 mm) for simultaneous insertion of implants (Fig. 1) . Sinus floor augmentation was carried out on both sides in 4 cases and one side in 7 cases for the patients, of whom 5 were partially and 6 completely edentulous.
Thus, a total of 15 sinus lifts augmentation procedures were completed.
Surgical procedure
All surgery procedures were completed under local anaesthesia by the same surgeon.
A remote palatal incision was carried out. Vertical releasing incisions were additionally made anteriorly and posteriorly. Next, a mucoperiosteal flap was prepared and elevated, allowing good access to the lateral sinus wall. Using a Lindemann burr a sinus window was outlined and the osteo-tomy was finished with a diamond round burr under continuous cooling using sterile saline solution. As the Schneiderian membrane was detached, the infractured lateral sinus wall was rotated medially. This technique was used to lift the sinus mucosa in a cranial direction (Figs 2-3) . The xenogenic bone graft material Bio-Oss A combined with venous blood was sampled from the vein of each patient's arm, and was then used to fill the cavity (Fig. 4) . The defect of the lateral sinus wall was covered using resorbable, collagenous membrane Bio-Gide A (Geistlich, Wolhusen, Switzerland). The mucoperiosteal flap was repositioned and sutured using non-resorbable suture material Gore-Tex A 5.0 (GTAM, W. L. Gore & Ass. Inc, Flagstaff, AZ, USA) (Fig. 5) .
The following postoperative regimen was applied: to avoid infection, the patients were treated with the antibiotic Augmentan A -500 mg, 4 times daily -(Beecham-Wü lfing, Neuss, Germany); to counter swelling in the nasal and sinus cavity, the patients were given Otriven A nasal drops (CIBAGeigy, Wehr, Germany), and to reduce pain and swelling Ibuprofen A -400 mg, 3 times daily -(Klinge Pharma, Mü nchen, Germany) was administered. The sutures were removed 14 days following surgery.
Patients were instructed to rinse twice daily over a period of 2 weeks using a 0.2% chlorohexidine gluconate solution. They were also advised not to wear their removable prosthesis for 14 days, and not to blow their noses. Following an average 6.8 months healing time, Brånemark implants (Nobel Biocare AB, Gö teborg, Sweden) were inserted . Some 22 cylindrical bone biopsies from the augmented posterior maxilla had previously been taken using a trephine burr with inner diameter 2 mm and outer diameter 3 mm. Implants were placed in the osteotomy sites obtained from biopsy sampling.
Histology
Preparation of the ground specimens. The trephine burrs were immersed in formalin for 48 h, rinsed in running water overnight and then dehydrated in serial steps (70%, 80%, 96% and 100%) of alcohol. The specimens were embedded in the plastic KPlast (Medim, Gießen, Germany).
The sawing and grinding technique according to Donath & Breuner (1982) was applied.
After hardening, 2 sections of approx. 300 mm thickness were cut parallel to the longitudinal axis of the trephine burrs using a diamond band saw (Exakt, Norderstedt, Germany). By microgrinding and polishing (Exakt) the sections were then reduced to a thickness of 100 mm and stained with toluidine blue and pyronine G (Fig. 9) . Histomorphometry A semiautomatic measurement technique was selected for the morphometric investigation. The operating system applied was Windows for Workgroups 3.11 (Microsoft, Munich, Germany) with its graphic user interface. Image processing was via the analysis program KS 300 (Zeiss, Jena, Germany).
The hardware required for comprehensive measurement of the sections was Prog/Res/3008 (Kontron Elektronik, Eching, Germany) and consisted of the light microscope Axioskop (Zeiss, Jena, Germany), a video camera, a video mixer and an IBM-compatible computer. The visual field of the light microscope was recorded by the video camera at a magnification of 100, and projected on-screen using the video mixer with the computer graphics of the image processing program KS 300. Special macro programming made it possible to ride over the surface of the Bio-Oss particles and newlyformed bone using the cursor. The nature of the surface could thus be automatically calculated by counting the number of pixels (Fig. 10) .
Since the visual field remained at the defined size of 0.5 mm 2 , the software was able to calculate both the percentage proportion of substitute material and newly-formed bone and, through differential 222 calculus, the proportion of soft tissue over the entire surface measured. During a second measurement phase, the cursor was used to mark the size of the Bio-Oss A particles and the regions over which these were covered by newly-formed bone. It was then possible to calculate the percentage proportion of Bio-Oss A granulate in direct contact with bone two-dimensionally.
The measuring field, the size of which corresponded to the size of the visual field of the microscope, could be optimally adjusted via manual adjustment of the cross-table. Measuring field selection was via visual control of the microscopic image on the monitor.
Two sections were obtained from each biopsy. The sections were of different width due to the round section of the trephine burr. This meant that each pair of ground specimens contained a singlerow measuring field and a double-row measuring field. The number of visual fields to be measured varied for individual specimen sections between 4 and 28. This was because the trephine burr was used to a different depth according to the length of the implants subsequently inserted.
Results

Clinical observation
All augmented sinuses healed well with no occurrence of symptoms indicating possible maxillary sinusitis. The resorbable Bio-Gide A membrane, used to cover the window osteotomy, was at no time or at any location freely exposed. There were 2 cases of nosebleed following the operation.
When the implants were surgically uncovered after an average 6 months, 4 of the 38 implants were found to be loose. One implant had to be explanted and the other 3, left as ''sleeping implants'', were not included in the superstructure. Thus, the implant survival rate was 89.5%. The patients were treated with either an implant-supported, removable prosthesis or a solely implantsupported superstructure. Studies on the longterm prognosis of these implants remain to be concluded.
Histological observations Clear identification of the Bio-Oss
A granulate in the histological preparations remained possible even after a healing phase of up to 9.5 months. The newly-formed bone was distinguishable from the Bio-Oss A granulate: the osseous lamellae of healthy living bone tissue contained osteocytes, located in the bevelled bone lacunae, which send out branched protoplasmic processes into the small bone canals.
Bio-Oss
A particles consisted of necrotic bone material, characterized by a lack of osteocyte nuclei. The osteocyte lacunae were empty and the lamellar layer was indistinct or completely removed. The size and shape of the Bio-Oss A granulate particles also identified clear differences in comparison to natural bone. While natural bone lamellae appeared long and thin, the particles of bone substitute material were short, thick and had sharp boundaries.
A further visible difference between the two components was in relation to color. Use of the previously-described staining method revealed that newly-formed bone was purple in contrast to the brighter purple-orange tone of the Bio-Oss A particles.
Individual particles were embedded in newlyformed bone, osteoid and soft tissue in various proportions. The newly-formed bone consisted mainly of woven bone, more mature lamellar bone only occurring in isolated cases. Histological analysis revealed that the bovine apatite particles were partly infiltrated by blood vessels and, in some places, penetrated by newly-formed bone. This confirms the properties of Bio-Oss A as an osteoconductive material.
However, in spite of the penetration osteoclastic activity could not be identified using the light microscope, i.e. that very slow Bio-Oss A resorption may be supposed, but could not be proven.
The cancellous bone trabeculae of the Bio-Oss A particles served as a conducting track for the newly-formed bone, which interconnected the individual particles. The soft tissue between these bone trabeculae contained connective tissue composed of various degrees of fibroblasts, collagenous fibers and blood vessels and showed no signs of inflammation. Table 3 and Fig. 11 show the results of the histomorphometric measurements of Bio-Oss A com- 
Histomorphometric analyses
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bined with venous blood. An average 14.7% (∫5.0%) of newly-formed bone was measured, the values for newly-formed bone varying from 4.1% to 24.6%. Xenogenic bone substitute material occupied an average 29.7% (∫7.8%) of the measured field. The block diagrams in Fig. 12 allow comparison of the histomorphometric results for individual patients and regions. The sections also show considerable differences in relation to osseous growth around the bovine apatite particles. On average 29.1% (∫8.1%) of the surface of the Bio-Oss A granulate was in direct contact with newly-formed bone. The measured values ranged between 7.5% and 59.8%.
Discussion
Sinus floor elevation is an established method of harvesting sufficient vertical bone from the posterior region of the maxilla to achieve good primary stability ahead of implant insertion (Smiler et al. 1992) . Even though this method has become routine with patients having too small a bone supply, the question as to which augmentation material is optimum has not been finally resolved. Clinically and histologically, the use of autogenous iliac crest bone provides the best results, but the side effects and complications involved in surgery to the iliac crest cannot be ignored. An ideal bone substitute material should incorporate into the host bone as well as autogenous bone, but, unlike autogenous bone, be available in unlimited quantities, either because synthetically manufactured or produced naturally. Recent years have seen an increase in the number of studies of tests relating to the use of hydroxylapatite, obtained synthetically or from basis materials such as coral, algae and bovine bone (Kasperk & Ewers 1986; Holmes et al. 1988; Klinge et al. 1992) .
In recent years, the suitability of xenogenic bone substitute material for filling bone defects has been demonstrated by experiments with rabbits (Schlickewei & Paul 1991; Spector 1994; Schmitt et al. 1997; Jensen et al. 1996) and dogs (Berglundh & Lindhe 1997) .
A more advanced, specific application for bovine apatite in dentistry, partly in combination with other transplant materials, has been investigated in maxillary sinus augmentation. Sinus floor elevation using xenograft has been successful both in animal-based research work with monkeys (Boyne 1993; Hü rzeler et al. 1997), dogs (Wetzel et al. 1995) and sheep (Haas et al. 1998) , and in therapeutic applications in humans (Valentini & Abensur 1997; Wallace et al. 1996) .
The degree of osseous integration is determined by the biological processes at the surface of the implant. Therefore, the degree of success of a maxillary sinus augmentation can be best assessed by examining the histological status of the bone at the implant surface. Thus, the benchmark for successful sinus augmentation is maximum osteogenesis of qualitatively high-grade living bone for osseous integration (Wallace et al. 1996) .
The extent of osseous penetration of xenogenic apatite depends on its properties of osteoconduction, i.e. the ability to act as a spacer and conducting structure for newly-forming bone. This arises from an interconnecting pore system and physical and chemical properties similar to those of human cancellous bone. Even without the de-224 monstrable resorption of the bone substitute material via osteoclasts, the porosity of the material provides an excellent basis for vascularization and penetration of associated cells which integration of the substitute material requires, sufficient vascularization being an absolute precondition to the osteogenetic process (Bereiter et al. 1991) .
Growth penetration of bone tissue is only ensured if pore diameter is at least 100 mm, and formation of osteo-like structures requires a pore diameter of 200 mm (Klawitter & Hulbert 1971) . The pore system of Bio-Oss A is architecturally structured to allow vascularization of new bone. High stability in the augmented region is achieved through integration of Bio-Oss A granulate into the new bone formations. Schlickewei & Paul (1991) have demonstrated the osteoconductive property of Bio-Oss A by using this material to fill 5 mm diameter drilled-hole defects in the femur of rabbits. After 6 months, no osseous extension was evident in empty control holes. In contrast, in the defects filled with BioOss A , bone had formed along the xenogenic substitute material.
An investigation into human response, clinically and histologically comparable to the present one, was that published by Valentini & Abensur in 1997 . In this study, 28 sinus elevations were completed using a combined transplant made of demineralized, freeze-dried bone and porous, deproteinized bovine bone on 20 patients, with insertion of 60 implants. A simultaneous approach was considered for a local bone supply greater than 5 mm, and delayed for a local bone supply less than 5 mm. The implantation success rate after 2 years was 90-96%. After 6 months insertion time, histological slides showed bridge-building between the apatite particles. After 12 months, the Bio-Oss A particles were fully integrated into new bone. Since the allogenic bone showed no invagination in woven bone, the authors recommended exclusive use of bovine substitute material.
After 8 weeks resting time, Jensen et al. (1996) observed 72% osseous growth around the particles of substitute material in bone defects drilled in the tibia of rabbits and filled with Bio-Oss A . In comparison, histological analysis of the human biopsies of our study after 4 to 10 months healing phase showed an arithmetic mean for direct contact of the Bio-Oss A particles to bone of only 29.1% (∫8.1%).
Because important aspects of the experimental conditions in animal experiments differ greatly from those encountered with humans, the results of such experiments must be treated with caution. A direct comparison of animal experiment-based results with clinical results obtained with humans is therefore not possible. The much greater osseous growth around the Bio-Oss A particles in the rabbit model can be ascribed to increased bone reconstruction rates in rodents. In the rabbit, physiological bone remodeling is approx. 3 times higher than in humans (Roberts et al. 1987) . Anatomical differences to humans in the region of the sinus (absence of Schneiderian membrane, no pneumatization) mean that the validity experiments involving dogs for humans is also limited (Wetzel et al. 1995) . Moreover, histomorphometrically higher percentages of bone in the augmentation material can be achieved in animals than is possible in studies of humans. With implantation of Bio-Oss A granulate in rabbits in bone defects created under animal experiment conditions, average bone densities after a 4-week resting time were found to be 68.9% (Schmitt et al. 1997) .
Presenting a single case, Valentini et al. (1998) have compared the percentage of bone in the sinus region augmented using Bio-Oss A with local bone. In contrast to an histomorphometrically measured bone density in the non-augmented maxillary crest section of 27%, the percentage of newly-formed bone in the augmented region was 28% at a substitute material density of 28%. Thus, the amount of space required by the bone substitute material appeared to limit itself to the bone marrow region. The authors could find no connection between Bio-Oss A and the amount of newly-formed, mineralized bone. At the same time, it should be noted that this publication makes reference to only 1 patient.
In their clinical study, Wheeler et al. (1996) 
used Interpore 200
A or Bio-Oss A in sinus lifting. Bone biopsies were removed after a 4-to 36-month resting time and histomorphometrically evaluated. Using hydroxylapatite alone, the resultant percentage of bone was 16.38%. These results concur with the value determined by ourselves with augmentation using Bio-Oss A with blood grafting: 14.7% (∫5.0%).
225
This compares with the known parameters for human iliac crest cancellous bone: the percentage of bone tissue in this region is approx. 20-25%, depending on age (Schenk 1991) . The bone densities we measured in the sinus augmented using Bio-Oss A vary considerably from the values of autogenous cancellous bone.
Since in the present study ethical considerations meant that only 1 bone biopsy per implant insertion was possible, a quantitative evaluation of the long-term development of new bone formation could not be completed, but was restricted to the actual condition at the time the biopsy took place.
In sinus augmentation on sheep using Bio-Oss A as augmentation material, Haas et al. (1998) have described an increase in implant-bone contact of 27.4% after 12 weeks to 34.7% after 26 weeks. This raises the question of whether the increase in bone density over time in animals also applies to humans. In our investigation, the bone density obtained did not increase in a progredient time curve. The healing response of individual patients appeared to have a much greater effect on new bone formation than the resting time of the xenograft.
Resorption is a further factor affecting the successful osseous penetration of the bone substitute material. This so-called biodegradation should take place at a time appropriate to activation of new bone formation, so that the integrity of the conducting structure is not put at risk. Should the bone substitute material survive as a conducting structure, the newly-formed bone tissue is merely a filler (Schenk 1991) .
In the literature, the resorption of bovine bone substitute material has been the subject of controversy. Some publications based on animal experiment-based research have detected histological evidence indicating resorption of Bio-Oss A (Klinge et al. 1992; Spector 1994; Wetzel et al. 1995; Berglundh & Lindhe 1997) . Schlickewei & Paul (1991) described resorption of the xenogenic material as physiological remodeling, which can be expected to become established in humans after a time lapse of 1-5 years.
Radiographic examination has been able to identify the presence of Bio-Oss A granulate even after a resting time of up to 7 years (Schlegel 1996) and histologically even 44 months after augmentation of the alveolar ridge of the maxilla (Skoglund et al. 1997) . This leads the authors to doubt the resorbability of the material. Osteoclastic activities seemed to affect the appositionally developed bone of the patient, itself oriented to the bovine pattern, rather than the bovine structure of the substitute material (Schlegel 1996) .
In the present study, the absence of resorption lacunae and the bone penetration into the substitute material nevertheless present allowed the conclusion that resorptive activity was slight. However, a quantitative evaluation was not possible since the initial percentage occupation by substitute material after sinus elevation was not known. Because of its porous structure, Bio-Oss A initially occupies 25-30% of the available space in the defect (Peetz 1997) . Given that the average density of the substitute material was 29.7% (∫7.8%), no significant degradation over the observation period can be assumed.
When interpreting the 89.5% implant success rate achieved at implant opening in this clinical study, it should be remembered that because of the limited quality and quantity of bone in the maxilla, the implant success rate is considerably lower than for the mandible (Adell et al. 1981) . In a long-term study of osseointegrated oral implants, the 5-7 year implant success rate for the maxilla is given as 84.9% (Albrektsson et al. 1988) . It remains to be determined whether these results for sinus regions augmented using Bio-Oss A can also be achieved long-term after implants have been subjected to prosthetic loading.
Conclusion
Compared with experimental animal investigations, the histomorphometric values for percentage of bone in the augmented sinus region of 14.7% are inferior.
However, both the histologically observed osseous integration of Bio-Oss A granulate and the good clinical results in the form of relatively high success rates up to the time of implant opening appear to support bovine apatite as a useful human bone substitute material where sinus augmentation precedes implanting. The osteoconductive properties of bovine apatite Bio-Oss A lead to the development of new bone formation both at the surface of the substitute material and as trabeculae between the Bio-Oss A particles of the substitute material. Long-term results following prosthetic loading of the inserted implants will have to prove whether an appropriate implant site can be obtained by augmentation using Bio-Oss A . The extent to which addition of autogenous bone to xenogenic substitute material positively affects the percentage of newly-formed bone, and thus the quality of the implant sites, remains to be tested in further investigations.
Résumé
Le but de l'étude présente a été d'évaluer la formation osseuse suite à l'épaississement du sinus maxillaire en utilisant un 
Resumen
La intenció n del presente estudio fue evaluar la formació n de hueso tras el aumento del seno maxilar usando material ó seo bovino de sustitució n Bio-Oss A en combinació n con sangre venosa por medio de examen histoló gico e histomorfométrico de biopsias humanas. Este involucró a un total de 15 procedimientos de elevació n del suelo del seno Ilevadas a cabo en 11 pacientes (media de edad de 49.6 añ os) de acuerdo con la técnica descrita de Tatum (1986) . La cavidad sinusal subantral fue aumentada usando apatita bovina combinada con sangre venosa. Tras un periodo medio de cicatrizació n de 6.8 meses, se usaron fresas de trépano para tomar 22 biopsias ó seas de la regió n aumentada del seno. Se insertaron entonces 38 implantes Brånemark A en las osteotomias resultantes del muestreo de hueso y en lugares regulares del maxilar posterior aumentado. El análisis histomorfométrico de las secciones de las biopsias de hueso preparadas de acuerdo con el método estándar de Donath y Breuner (1982) produjeron un porcentaje medio de hueso neoformado del 14.7% (∫5%) y una proporció n de material sustitutivo ó seo residual xenogénico del 29.7% (∫7.8%). El 29.1% (∫8.1%) de la superficie de los gránulos de Bio-Oss A estaba en contacto directo con el hueso neoformado. Histoló gicamente, el hueso nuevamente desarrollado fue evidente, en parte invaginando las partículas de apatitas y formando puentes en forma de travéculas entre las partículas individuales de Bio-Oss A . A pesar de la ausencia de actividad osteoclástica, el crecimiento hacia dentro de hueso indica una lenta reabsorció n del material ó seo de injerto xenogénico. Cuando se descubrieron los implantes, tras un periodo de cicatrizació n de seis meses, 4 de los 38 implantes de habían aflojado. De estos 4 implants, uno tubo que ser subsecuentemente extraído mientras los otros permanecieron como implantes durmientes y no se incluyeron en la superestructura de implantes. De este modo, el índice de supervivencia clínico resultante antes de la carga protésica fue del 89.5%.
